ASX: BRN Inconsistencies found Human review required

BrainChip continuous disclosure
consistency review

The May 2026 AGM addresses read against the September 2026 Q2 investor presentation, in both directions. Fifteen statements audited; eight carry a finding, two of them high severity.

As at 15 September 2026 · automated analysis · not subject to external audit or review

Full report

Disclosure consistency report

Every finding in full — the 15-statement verification matrix, the forward-looking assessment against Listing Rule 3.4, side-by-side quotations and the analyst Q&A pack.

Presentation

13-slide review deck

The same analysis for the disclosure committee: what moved between the two documents, the four findings, and the four things to settle before the next investor touchpoint.